AbbVie
ABBV
ABBV
2,956 hedge funds and large institutions have $166B invested in AbbVie in 2022 Q3 according to their latest regulatory filings, with 137 funds opening new positions, 1,297 increasing their positions, 1,153 reducing their positions, and 130 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,956
Holders Change
-36
Holders Change %
-1.2%
% of All Funds
51.12%
Holding in Top 10
277
Holding in Top 10 Change
-52
Holding in Top 10 Change %
-15.81%
% of All Funds
4.79%
New
137
Increased
1,297
Reduced
1,153
Closed
130
Calls
$2.32B
Puts
$2.05B
Net Calls
+$272M
Net Calls Change
-$205M
Top Buyers
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$844M |
| 2 |
GQG Partners
Ft. Lauderdale,
Florida
|
-$404M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$321M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$304M |
| 5 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$261M |
